- Clinical outcomes following switch from venlafaxine ER to desvenlafaxine in nonresponders and respondersC J Guico-Pabia
Pfizer Inc, Collegeville, PA, USA
Curr Med Res Opin 27:1815-26. 2011..This post hoc analysis examined efficacy and tolerability of open-label desvenlafaxine in patients with major depressive disorder switched from blinded placebo, venlafaxine extended release (ER), or desvenlafaxine...
- Assessing the relationship between functional impairment/recovery and depression severity: a pooled analysisChristine J Guico-Pabia
Pfizer Inc, Collegeville, Pennsylvania 19426, USA
Int Clin Psychopharmacol 27:1-7. 2012..A better understanding of the relationship between depressive symptoms and functional impairment and well-being may provide clinicians with a more comprehensive means of assessing treatment effects in major depressive disorder...